These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16104180)

  • 21. Treatment of ascites by continuous ultrafiltration and reinfusion of protein concentrate.
    Parbhoo SP; Ajdukiewicz A; Sherlock S
    Lancet; 1974 May; 1(7864):949-52. PubMed ID: 4133642
    [No Abstract]   [Full Text] [Related]  

  • 22. [Electrolyte and osmolar changes during extracorporeal ultrafiltration of hepatic cirrhosis ascites].
    De Paoli Vitali E; Stabellini N; Fiocchi O; Corcione S; Boccia S; Farinelli A
    Boll Soc Ital Biol Sper; 1983 Jun; 59(6):880-6. PubMed ID: 6882590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peritoneal ports for treatment of intractable ascites.
    Savin MA; Kirsch MJ; Romano WJ; Wang SK; Arpasi PJ; Mazon CD
    J Vasc Interv Radiol; 2005 Mar; 16(3):363-8. PubMed ID: 15758132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Long-term dialysis treatment of the ascites in a liver cirrhosis patient].
    Deliĭski M; Kiriakov Z; Vladov V; Angelov A; Todorov N
    Khirurgiia (Sofiia); 1985; 38(2):65-7. PubMed ID: 4010212
    [No Abstract]   [Full Text] [Related]  

  • 25. Continuous arterio-venous ultrafiltration in cirrhotic patients with ascites or renal failure.
    Epstein M; Perez GO; Bedoya LA; Molina R
    Int J Artif Organs; 1986 Jul; 9(4):253-6. PubMed ID: 3781651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study.
    Appenrodt B; Wolf A; Grünhage F; Trebicka J; Schepke M; Rabe C; Lammert F; Sauerbruch T; Heller J
    Liver Int; 2008 Aug; 28(7):1019-25. PubMed ID: 18410283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A multilevel method of treatment of ascites with liver cirrhosis].
    Pirtskhalava TL; Granov DA
    Vestn Khir Im I I Grek; 2003; 162(5):36-9. PubMed ID: 14768101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spontaneous dialytic ultrafiltration with intraperitoneal reinfusion of the concentrate in 15 cirrhotic patients with intractable ascites.
    Cadranel JF; Grippon P; Gargot D; Lunel F; Bernard B; Valla D; Opolon P
    Int J Artif Organs; 1992 Mar; 15(3):168-71. PubMed ID: 1521902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of hepatic cirrhosis ascites by reinfusion of concentrated ascitic fluid using artificial kidney ultrafiltration (author's transl)].
    Chen CY
    Zhonghua Nei Ke Za Zhi; 1979; 18(5):374-6. PubMed ID: 555943
    [No Abstract]   [Full Text] [Related]  

  • 30. Management of ascites in cirrhosis.
    Sandhu BS; Sanyal AJ
    Clin Liver Dis; 2005 Nov; 9(4):715-32, viii. PubMed ID: 16207572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of ascites by continuous ultrafiltration and reinfusion of protein concentrate.
    Parbhoo SP; Ajdukiewicz A; Sherlock S
    Gut; 1973 May; 14(5):421-2. PubMed ID: 4716516
    [No Abstract]   [Full Text] [Related]  

  • 32. Mesocaval shunt as an alternative treatment for persistent ascites after liver transplantation: case reports.
    Taner CB; Nguyen JH
    Transplant Proc; 2008 Jun; 40(5):1534-5. PubMed ID: 18589145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review article: Management of ascites and associated complications in patients with cirrhosis.
    Kuiper JJ; de Man RA; van Buuren HR
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():183-93. PubMed ID: 18081661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyponatremia in cirrhosis: Results of a patient population survey.
    Angeli P; Wong F; Watson H; Ginès P;
    Hepatology; 2006 Dec; 44(6):1535-42. PubMed ID: 17133458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proceedings: A simpler, cheaper, more effective, safe method for removal of ascites.
    James O; Ward M; Hoenich N
    Gut; 1976 May; 17(5):391. PubMed ID: 1278739
    [No Abstract]   [Full Text] [Related]  

  • 36. The management of ascites and hyponatremia in cirrhosis.
    Ginès P; Cárdenas A
    Semin Liver Dis; 2008 Feb; 28(1):43-58. PubMed ID: 18293276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transjugular intrahepatic portosystemic shunts in hemodialysis-dependent patients and patients with advanced renal insufficiency: safety, caution, and encephalopathy.
    Haskal ZJ; Radhakrishnan J
    J Vasc Interv Radiol; 2008 Apr; 19(4):516-20. PubMed ID: 18375295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid: a randomised controlled pilot trail.
    Moreau R; Valla DC; Durand-Zaleski I; Bronowicki JP; Durand F; Chaput JC; Dadamessi I; Silvain C; Bonny C; Oberti F; Gournay J; Lebrec D; Grouin JM; Guémas E; Golly D; Padrazzi B; Tellier Z
    Liver Int; 2006 Feb; 26(1):46-54. PubMed ID: 16420509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of refractory ascites using nocturnal home hemodialysis.
    Pauly RP; Sood MM; Chan CT
    Semin Dial; 2008; 21(4):367-70. PubMed ID: 18573138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Secondary Aeromonas peritonitis is associated with polymicrobial ascites culture and absence of liver cirrhosis compared to primary Aeromonas peritonitis.
    Huang LJ; Chen HP; Chen TL; Siu LK; Fung CP; Lee FY; Liu CY
    APMIS; 2006 Nov; 114(11):772-8. PubMed ID: 17078857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.